Global Stereotactic Surgery Devices Market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 3.2 billion by 2030 from USD 2.3 billion in 2018. The market is driven by factors such as increasing prevalence of neurological disorders and rising demand for minimally invasive surgical procedures. The global market for stereotactic surgery devices was valued at USD 2.3 billion in 2018 and is projected to reach USD 3.2 billion by 2030, growing at a CAGR of 5.5% during the forecast period from 2021-2030. The market has been segmented on the basis of type into gamma knife, proton beam, and line accelerator machines; application into brain tumor treatment, arteriovenous malformations treatment, trigeminal neuralgia (TN), Parkinson’s disease (PD), and epilepsy; and region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific & Middle East & Africa (APMEA). -The global Stereotactic Surgery Devices market is expected to grow at a CAGR of 5.5% during the forecast period, 2018-2025. -The global Stereotactic Surgery Devices market is expected to reach USD 3.2 billion by 2025 from USD 2.1 billion in 2018, growing at a CAGR of 5.5%. -Increasing prevalence of neurological disorders such as Parkinson’s disease and Alzheimer’s disease are driving the growth of the global Stereotactic Surgery Devices market. -Increasing number of neurosurgeons and neurologists are also driving the growth of the global Stereotactic Surgery Devices market due to increasing demand for minimally invasive procedures for brain tumors and other neurological disorders such as Parkinson’s disease and Alzheimer’s disease which require less recovery time than traditional surgeries. -Growing geriatric population base is also driving the growth of this market due to increasing incidence rates for neurological disorders among elderly people with age related cognitive decline or dementia which requires surgical intervention in order to treat them effectively without causing any further damage or deterioration in their condition.
Industry Growth Insights published a new data on “Stereotactic Surgery Devices Market”. The research report is titled “Stereotactic Surgery Devices Market research by Types (Gamma Knife, Proton Beam, Line Accelerator Machines), By Applications (Brain Tumor Treatment, Arteriovenous Malformations Treatment, Trigeminal Neuralgia, Parkinsons Disease, Epilepsy), By Players/Companies CIRS, IBA, Inomed, Elekta AB, Micromar, adeor Medical AG, Alliance Oncology, Monteris Medical, Modus Medical Devices, Raysearch Laboratories”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Stereotactic Surgery Devices Market Research Report
By Type
Gamma Knife, Proton Beam, Line Accelerator Machines
By Application
Brain Tumor Treatment, Arteriovenous Malformations Treatment, Trigeminal Neuralgia, Parkinsons Disease, Epilepsy
By Companies
CIRS, IBA, Inomed, Elekta AB, Micromar, adeor Medical AG, Alliance Oncology, Monteris Medical, Modus Medical Devices, Raysearch Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Stereotactic Surgery Devices Market Report Segments:
The global Stereotactic Surgery Devices market is segmented on the basis of:
Types
Gamma Knife, Proton Beam, Line Accelerator Machines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Brain Tumor Treatment, Arteriovenous Malformations Treatment, Trigeminal Neuralgia, Parkinsons Disease, Epilepsy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CIRS
- IBA
- Inomed
- Elekta AB
- Micromar
- adeor Medical AG
- Alliance Oncology
- Monteris Medical
- Modus Medical Devices
- Raysearch Laboratories
Highlights of The Stereotactic Surgery Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gamma Knife
- Proton Beam
- Line Accelerator Machines
- By Application:
- Brain Tumor Treatment
- Arteriovenous Malformations Treatment
- Trigeminal Neuralgia
- Parkinsons Disease
- Epilepsy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stereotactic Surgery Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Stereotactic surgery devices are medical tools that allow for precise placement of surgical instruments inside the body. This technology is often used to treat conditions such as cancer, epilepsy, and brain tumors.
Some of the major players in the stereotactic surgery devices market are CIRS, IBA, Inomed, Elekta AB, Micromar, adeor Medical AG, Alliance Oncology, Monteris Medical, Modus Medical Devices, Raysearch Laboratories.
The stereotactic surgery devices market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Stereotactic Surgery Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Stereotactic Surgery Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Stereotactic Surgery Devices Market - Supply Chain
4.5. Global Stereotactic Surgery Devices Market Forecast
4.5.1. Stereotactic Surgery Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Stereotactic Surgery Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Stereotactic Surgery Devices Market Absolute $ Opportunity
5. Global Stereotactic Surgery Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Stereotactic Surgery Devices Market Size and Volume Forecast by Type
5.3.1. Gamma Knife
5.3.2. Proton Beam
5.3.3. Line Accelerator Machines
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Stereotactic Surgery Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Stereotactic Surgery Devices Market Size and Volume Forecast by Application
6.3.1. Brain Tumor Treatment
6.3.2. Arteriovenous Malformations Treatment
6.3.3. Trigeminal Neuralgia
6.3.4. Parkinsons Disease
6.3.5. Epilepsy
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Stereotactic Surgery Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Stereotactic Surgery Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Stereotactic Surgery Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Stereotactic Surgery Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Stereotactic Surgery Devices Demand Share Forecast, 2019-2029
9. North America Stereotactic Surgery Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Stereotactic Surgery Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Stereotactic Surgery Devices Market Size and Volume Forecast by Application
9.4.1. Brain Tumor Treatment
9.4.2. Arteriovenous Malformations Treatment
9.4.3. Trigeminal Neuralgia
9.4.4. Parkinsons Disease
9.4.5. Epilepsy
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Stereotactic Surgery Devices Market Size and Volume Forecast by Type
9.7.1. Gamma Knife
9.7.2. Proton Beam
9.7.3. Line Accelerator Machines
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Stereotactic Surgery Devices Demand Share Forecast, 2019-2029
10. Latin America Stereotactic Surgery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Stereotactic Surgery Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Stereotactic Surgery Devices Market Size and Volume Forecast by Application
10.4.1. Brain Tumor Treatment
10.4.2. Arteriovenous Malformations Treatment
10.4.3. Trigeminal Neuralgia
10.4.4. Parkinsons Disease
10.4.5. Epilepsy
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Stereotactic Surgery Devices Market Size and Volume Forecast by Type
10.7.1. Gamma Knife
10.7.2. Proton Beam
10.7.3. Line Accelerator Machines
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Stereotactic Surgery Devices Demand Share Forecast, 2019-2029
11. Europe Stereotactic Surgery Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Stereotactic Surgery Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Stereotactic Surgery Devices Market Size and Volume Forecast by Application
11.4.1. Brain Tumor Treatment
11.4.2. Arteriovenous Malformations Treatment
11.4.3. Trigeminal Neuralgia
11.4.4. Parkinsons Disease
11.4.5. Epilepsy
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Stereotactic Surgery Devices Market Size and Volume Forecast by Type
11.7.1. Gamma Knife
11.7.2. Proton Beam
11.7.3. Line Accelerator Machines
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Stereotactic Surgery Devices Demand Share, 2019-2029
12. Asia Pacific Stereotactic Surgery Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Stereotactic Surgery Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Stereotactic Surgery Devices Market Size and Volume Forecast by Application
12.4.1. Brain Tumor Treatment
12.4.2. Arteriovenous Malformations Treatment
12.4.3. Trigeminal Neuralgia
12.4.4. Parkinsons Disease
12.4.5. Epilepsy
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Stereotactic Surgery Devices Market Size and Volume Forecast by Type
12.7.1. Gamma Knife
12.7.2. Proton Beam
12.7.3. Line Accelerator Machines
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Stereotactic Surgery Devices Demand Share, 2019-2029
13. Middle East & Africa Stereotactic Surgery Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Stereotactic Surgery Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Stereotactic Surgery Devices Market Size and Volume Forecast by Application
13.4.1. Brain Tumor Treatment
13.4.2. Arteriovenous Malformations Treatment
13.4.3. Trigeminal Neuralgia
13.4.4. Parkinsons Disease
13.4.5. Epilepsy
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Stereotactic Surgery Devices Market Size and Volume Forecast by Type
13.7.1. Gamma Knife
13.7.2. Proton Beam
13.7.3. Line Accelerator Machines
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Stereotactic Surgery Devices Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Stereotactic Surgery Devices Market: Market Share Analysis
14.2. Stereotactic Surgery Devices Distributors and Customers
14.3. Stereotactic Surgery Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. CIRS
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. IBA
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Inomed
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Elekta AB
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Micromar
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. adeor Medical AG
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Alliance Oncology
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Monteris Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Modus Medical Devices
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Raysearch Laboratories
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook